About Walter Ogier
Walter Ogier is a director at Thetis Pharmaceuticals.
Walter Ogier first appears on SEC filings in 2017.
Experience
This experience comes from Walter Ogier's profile and from SEC filings. For roles taken from filings, the years are when the filings name Walter Ogier in the role, so the role may have started earlier or lasted longer.
Thetis Pharmaceuticals LLC Current
Member, Board of Managers
2016 – Present · Deep River, CT
Develops oral medicines for people with inflammatory bowel disease and solid tumors.
WC
Williams College Current
Member, Class of 1978 Reunion Fund Committee
2003 – Present
EI
Eledon Pharmaceuticals, Inc.
Member, Board of Directors
2020 – 2024
TL
Therapeutix, LLC
Managing Director
2007 – 2024
NI
Nemucore Medical Innovations, Inc.
Member, Board of Directors
2018 – 2022
AI
Anelixis Therapeutics, Inc.
Chairman and Director
2017 – 2020
RL
Regenacy Pharmaceuticals LLC
Member Board Of Directors
2016 – 2020
BI
Biothera Pharmaceuticals, Inc.
Member, Board of Directors
2014 – 2020
AI
Acetylon Pharmaceuticals, Inc.
President, Chief Executive Officer and Director
2008 – 2016
AI
Arbios Systems, Inc.
President, Chief Executive Officer and Director
2005 – 2007
BB
bluebird bio
President, Chief Executive Officer and Director
2001 – 2005
BI
BioTransplant, Inc.
President and COO
2001
EI
Eligix, Inc.
President, Chief Executive Officer and Director
1997 – 2001
AB
Aastrom Biosciences
Vice President, Marketing
1994 – 1997
BI
Baxter International Inc.
Immunotherapy Business Development
1986 – 1994
SI
SRI International
Industrial Economist, Staff Scientist, etc.
1979 – 1985
Key Colleagues at Startups
The people Walter Ogier works with at each company, as listed on that company's latest Form D.
Thetis Pharmaceuticals LLC · Form D, Oct 13, 2026
GM
Gary Mathias
Chief Executive Officer and director
FS
Frank Sciavolino
Director
DW
Dennis Willson
Director
FC
Fabio Cataldi
Director
DC
David Cook
Director